UnitedHealth Group Inc (UNH)
Industry Healthcare Plans
This stock can be held in an Investment ISA and an Investment Account
Sell
$287.57
Buy
$287.70
$17.56 (+6.40%)
Prices updated at 17 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
Prices in USD
UnitedHealth Group Inc is a diversified health care company in the United States. It designs products, provides services and applies technologies that improve access to health and well-being services, and make health care more affordable.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 371,622m | 400,278m | |
| 90,958m | 89,399m | |
| 32,358m | 32,287m | |
| 8.71 | 8.07 | |
| 22,381m | 14,405m | |
| 36,330m | 28,076m | |
| Sales, General and administrative | - | - |
| Interest expenses | 3,246m | 3,906m |
| Provision for income taxes | 5,968m | 4,829m |
| Operating expenses | 58,600m | 57,112m |
| Income before taxes | 29,112m | 20,071m |
| Net income available to common shareholders | 22,381m | 14,405m |
| 24.12 | 15.64 | |
| Net interest income | -3,246m | -3,906m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 23.86 | 15.51 |
| Free cash flow per share | 28.0701 | 14.0742 |
| Book value/share | 91.4437 | 103.3169 |
| Debt equity ratio | 0.65644 | 0.780926 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 78,437m | 85,779m |
| Current liabilities | 99,054m | 103,769m |
| Total capital | 147,019m | 165,017m |
| Total debt | 62,537m | 76,904m |
| Total equity | 88,756m | 92,658m |
| Total non current liabilities | - | - |
| Loans | 58,263m | 72,359m |
| Total assets | 273,720m | 298,278m |
| Total liabilities | - | - |
| Cash and cash equivalents | 25,427m | 25,312m |
| Common stock | 924m | 915m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 23,365m | 25,427m |
| Cash dividends paid | -6,761m | -7,533m |
| 25,682m | 20,705m | |
| Investments (gains) losses | -15,574m | -20,527m |
| 25,427m | 25,312m | |
| Net income | - | - |
| 29,068m | 24,204m | |
| -3,386m | -3,499m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
